DIO1 and neoplasm: This is in agreement with our previous study showing tumor-specific and patient-specific splicing patterns of type 1 iodothyronine deiodinase [4] and with other studies, showing that ccRCC is characterized by molecular heterogeneity and can be separated into gene expression subgroups [31]–[33].